NZ601028B - Carbon Dioxide Gas Removal From a Fluid Circuit of a Dialysis Device - Google Patents
Carbon Dioxide Gas Removal From a Fluid Circuit of a Dialysis Device Download PDFInfo
- Publication number
- NZ601028B NZ601028B NZ601028A NZ60102812A NZ601028B NZ 601028 B NZ601028 B NZ 601028B NZ 601028 A NZ601028 A NZ 601028A NZ 60102812 A NZ60102812 A NZ 60102812A NZ 601028 B NZ601028 B NZ 601028B
- Authority
- NZ
- New Zealand
- Prior art keywords
- dialysate
- housing
- gas
- degassing device
- inches
- Prior art date
Links
- 229910002092 carbon dioxide Inorganic materials 0.000 title description 23
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title description 20
- 239000001569 carbon dioxide Substances 0.000 title description 20
- 238000000502 dialysis Methods 0.000 title description 12
- 239000012530 fluid Substances 0.000 title description 8
- 108010046334 Urease Proteins 0.000 claims abstract description 17
- 230000008929 regeneration Effects 0.000 claims abstract description 8
- 238000011069 regeneration method Methods 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims description 22
- 239000003610 charcoal Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 abstract description 6
- 238000007872 degassing Methods 0.000 description 42
- 239000007789 gas Substances 0.000 description 41
- 239000002594 sorbent Substances 0.000 description 17
- 230000002209 hydrophobic Effects 0.000 description 13
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 13
- 210000004369 Blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 239000004202 carbamide Substances 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 6
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 229910001928 zirconium oxide Inorganic materials 0.000 description 4
- 229910000166 zirconium phosphate Inorganic materials 0.000 description 4
- LEHFSLREWWMLPU-UHFFFAOYSA-B zirconium(4+);tetraphosphate Chemical compound [Zr+4].[Zr+4].[Zr+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O LEHFSLREWWMLPU-UHFFFAOYSA-B 0.000 description 4
- 210000003734 Kidney Anatomy 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- -1 ammonium ions Chemical class 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229940109239 Creatinine Drugs 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000006011 modification reaction Methods 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000000541 pulsatile Effects 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- PPNXXZIBFHTHDM-UHFFFAOYSA-N Aluminium phosphide Chemical compound P#[Al] PPNXXZIBFHTHDM-UHFFFAOYSA-N 0.000 description 1
- PRKQVKDSMLBJBJ-UHFFFAOYSA-N Ammonium carbonate Chemical compound N.N.OC(O)=O PRKQVKDSMLBJBJ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000002000 Electrolyte additive Substances 0.000 description 1
- 229960002897 Heparin Drugs 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N Heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 206010038444 Renal failure chronic Diseases 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 230000003278 mimic Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000000737 periodic Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1656—Apparatus for preparing dialysates
- A61M1/1658—Degasification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1694—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
- A61M1/1696—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/75—General characteristics of the apparatus with filters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0031—Degasification of liquids by filtration
Abstract
Patent 601028 A dialysate regeneration system is disclosed with urease, a dialyzer, and a housing with an external wall, where the external wall is exposed to atmosphere and comprises a material that passes gas but does not pass liquid and where the housing is positioned between the urease and dialyzer. dialyzer.
Description
CARBON DIOXIDE GAS REMOVAL FROM A FLUID CIRCUIT
OF A DIALYSIS DEVICE
CROSS-REFERENCE
The present application relies on US. Provisional Application No. 61/021,965, filed on
y 18, 2008, for priority and is herein incorporated by reference.
FIELD OF THE INVENTION
The present invention generally relates to the field of alysis, and more specifically
to a method and system of efficiently removing carbon e, or any gas, from the dialysatc
circuit of a dialysis System without mising the solute-removal performance of a
hemodialysis device.
OUND OF THE INVENTION
Closed loop multi-pass sorbent based hemodialyzers have the advantage of being
portable and compact while being able to rate dialysatc using a plurality of sorbents.
Typically these sorbents are used in disposable cartridges/canisters and comprise sorbent
ition layers similar to those used in prior systems, Such as urease, zirconium phOSphate,
s zirconium oxide and activated carbon. As spent dialysatc sing urea, diffused
from impure blood in the dialyzer, passes through prior art sorbent cartridges, carbon dioxide and
ammonia are produced as two unwanted byproducts of the chemical reactions. While ammonia is
adsorbed in zirconium-based cartridges, carbon dioxide is not captured, mixes in the dialysate,
and manifests as carbon dioxide bubbles in the dialysate circuit. Large amounts of carbon
dioxide leave the liquid phase and interfere with the smooth g of dialysatc. In addition
other dissolved gases may exit from the liquid phase during processing adding to the volume of
gas in the system.
Accordingly, there is a need for a degassing device that can remove unwanted carbon
dioxide, and other gases, from the dialysate circuit. The degassing device needs to be
particularly suitable for a le hemodialyzer, where the orientation ofthe dialyzer should not
disrupt or degrade the efficiency of the degassing device. At the same time, the degassing device
needs to be small in size, light and low cost so that it can be a disposable component.
SUMMARY OF THE ION
It is an object of the present ion to provide a degassing device that efficiently vents
or removes carbon-dioxide, and other gas, bubbles, from dialysate t, that are produced from
urea split by urease in the sorbent system of a is device.
It is also an object of the present ion to have a degassing device that is particularly
le for a portable hemodialyzer, such as one configured as a portable artificial kidney
(PAK), where the orientation of the dialyzer should not disrupt or degrade the efficiency of the
degassing device.
Accordingly, it is another object of the present invention the degassing device needs to be
small in size, light and low cost so that it can be a disposable component.
In one embodiment, the degassing device of the present invention comprises two annular
concentric rings that make up inner and outer gs. While the upper end of the inner housing
is open, the upper end of‘ the outer housing is sealed with a microporous, hydrophobic membrane
that allows gases to pass through but does not allow liquids to pass. A gap is maintained between
the open upper end of the inner housing and the membrane. The annular concentric housings
define an inner first chamber and an outer second chamber. During dialysis, dialysate mixed with
carbon-dioxide enters into and moves up the outer second chamber causing carbon dioxide to be
automatically separated from the dialysate thereby forming small carbon dioxide bubbles that are
vented out through the microporous hobic membrane, while the dialysate overflows into
the inner first chamber and moves out of the degassing device.
In one embodiment, the present ion is directed to a degassing device comprising a)
a first inner chamber, b) a
a first housing having an inlet, a first length and an inner wall defining
second housing oned within said first inner chamber in an annular relation to the first
housing wherein the second housing has an outer wall, an outlet, at second length and an inner
wall defining a second inner chamber, wherein the second length is less than the first length, and
wherein a space between the first length and second length defines a gap, c) a flowpath through
said degassing device wherein said flowpath is defined by the inlet, the gap, and the outlet, and
d) a hydrophobic membrane oned proximate to said gap.
Optionally, the degassing device has a gap between about 0.02 inches and 0.1 inches, has
the second housing
a space between said inner wall of the first housing and outer wall of
between about 0.04 to 0.24 inches, and is capable of removing substantially all gas from dialysate
at flow rates between 20 ml/min and 450 ml/min. Optionally, the second housing includes a filter,
the filter is approximately 0.1 to 0.4 inches thick, and the hydrophobic membrane is oned a
distance from the second housing wherein the distance is equal to the gap.
Optionally, the inlet and outlet are positioned on a same side of said degassing device.
Fluid having gas flows into the first inner chamber through said inlet, flows through said gap,
flows past the hydrophobic membrane, flows into said second inner r. and flows through
said , n gas passes through the hobic membrane and wherein liquid does not
pass through said hydrophobic membrane. Optionally, a dialysate circuit includes a dialysate
regeneration system with urease, a dialyzer, and this degassing device, which is positioned
between the urease and the dialyzer.
In another embodiment, the present invention is directed to a dialysate circuit including a)
wherein
a dialysate regeneration system including urease, b) a housing including an external wall,
the external wall is exposed to atmosphere and wherein the external wall includes a material that
wherein said housing is positioned between
passes gas but does not pass liquid, and c) a dialyzer,
the urease and dialyzer. The housing preferably is just a tube, a section of tubing, or a coil of
tubing with nothing internal to the tube (the inner chamber defined by the external walls is devoid
of any ures or ctions) and with the external wall exposed to atmosphere, or at least to
an area external to the degassing device.
Optionally, the dialysate t es a membrane that is between 0.5 feet to 16 feet
long, has an outer diameter of about 0.1 to 0.45 , or has an inner diameter of about 0.1 to 0.4
inches. Optionally, the housing (degassing ) removes substantially all gas from the dialysate
at or below 10 psi.
at flow rates from about 20 ml/min to 200 ml/min or at internal pressures
Optionally, the dialysate regeneration system includes charcoal and the housing is positioned
between the charcoal and dialyzer.
BRIEF DESCRIPTION OF THE DRAWINGS
These and other features and advantages of the present invention will be appreciated, as
considered
they become better understood by reference to the following detailed description when
in tion with the accompanying drawings, wherein:
Figure 1 is a schematic illustration of an ment of an ary le dialysis
system;
Figure 2 is a schematic illustration of an exemplary process flow for performing dialysis;
Figure 3 is a m depicting an exemplary embodiment of the degassing device of the
t invention;
Figure 4 is a diagram depicting another ary embodiment of the degassing device
of the present invention;
Figure 5a depicts a scaled up degassing device in relation to a dialyzer; and
Figure 5b depicts another view of a degassing device sing material that passes gas
but not liquid.
DETAILED DESCRIPTION OF THE INVENTION
While the present invention may be embodied in many different forms, for the purpose of
promoting an understanding of the invention, reference will now be made to the embodiments
rated in the drawings and specific language will be used to describe the same. It will
nevertheless be understood that no limitation of the scope of the invention is thereby intended.
The present specification incorporates by reference co-pending, co-assigned US. Patent
ation Nos. 12/324,924, 12/210,080, 12/238,055, 12/237,914, 12/249,090, and 12/245,397
and third party owned US. Patent No. 6,960,179, U.S. Patent Application No 10/940,862,
/846,618, 1 ”427,267, 11/500,572 and PCT Application No. PCT/USO6/30923.
Closed loop multi-pass sorbent based is systems regenerate dialysate for reuse by
passing spent dialysatc through a regeneration section comprising a plurality of sorbent
cartridges and suitable additives. A l sorbent cartridge system comprises a urease cartridge,
and an activated carbon
a zirconium phosphate cartridge, a hydrous zirconium oxide cartridge
cartridge. Those of ordinary skill in the art will recognize that these sorbents are similar to the
sorbents employed by the commercially available REDYTM System.
As spent ate passes through the REDYTM sorbent system the conversion of urea to
ammonium carbonate, the exchange of ammonium ions for en ions, and the reaction of
the hydrogen ions with carbonate in the sorbent system, produces substantial amounts of carbon
dioxide. These large amounts of carbon dioxide that leave the liquid phase and the ensuing
bubbles interfere with smooth pumping of dialysate and therefore need to be removed from the
system. In addition, other gases may leave the liquid phase and, together with the carbon dioxide,
presents bubbles that need to be removed.
Accordingly, the present invention is a degassing device that functions to remove carbon
dioxide or any other gas from closed circuit dialysis s. The degassing device ofthe
present invention is suitable for functioning in any orientation apart from being small in size and
low cost enough to be disposable thus eliminating the need for periodic cleaning and
sterilization.
Figure 4 shows one ment ofthe ing device 400 of the present invention
comprising two annular cylindrical housings 405, 410. The housings 405, 410 are concentric.
The upper end of the inner housing 405 is Open and forms a circular rim 404. The upper end of
the outer h0using 410 is sealed with a microporous, hydrophobic membrane 415 that allows
The hydrophobic membrane can be of
gases to pass through but does not allow s to pass.
GoreTM hydrophobic
any suitable type, including a PALLTM hydrophobic membrane, a
membrane, including model numbers SMPL-MMT317, MMT-RD-OOl, -OOZB and
MMT-RD-OOZA. A gap exists between the upper end of the inner housing 405 and the
hydrophobic membrane sealed upper end of the outer g 410. The gap is sized to allow gas
bubble passage within the gap. Typical dimensions from .002” to .025”, and more particularly
defines
from 0.05” to 0.15”, have been used in the preferred embodiment. The inner housing 405
inner and the outer housings
an inner first chamber 401 while the concentric region between the
orifice at
405, 410 constitutes a second chamber 411. An inlet tube 420 is connected to an inlet
the first
the second chamber 411 while an outlet tube 425 is connected to an outlet orifice at
chamber 401.
In one embodiment, the inner first housing 405 has a discontinuous internal surface to
provide areas upon which gas within the liquid can nucleate, collect, form bubbles, and migrate
In one embodiment, the inner first housing
up and h the top hydrophobic membrane.
comprises a filter membrane which is approximately 0.1 to 0.4 inches thick (more particularly
0.25 inches). has an inner diameter of 0.5 to 1.5 inches (more particularly 1 inch), and an outer
diameter of 0.5 inches to 2.5 inches (more ularly 1.5 inches). In another embodiment, the
405 and hydrophobic ne 415 is about 0.02
gap at the top, n the inner first housing
first housing 405
to 0.1 inches (more particularly 0.064), the gap n the outside of the inner
and the inner wall of the outer housing 410 is about 0.04 to 0.24 inches (more particularly 0.141
inches), and there is no gap between the inner first housing 405 and the base ofthe degassing
device 400. In one embodiment, the degassing device 400 has a height of l to 5 inches (more
particularly three inches) and an outer diameter of .5 to 3 inches (and more ularly 1.75
inches). The degassing device is able to substantially remove all gas from the dialysate at a flow
of 20 ml/min to 450 mein (more particularly 250 ml/min).
During hemodialysis, dialysate mixed with carbon dioxide enters the inlet tube 420 and
overflows into the inner first chamber 401
passes into the concentric second chamber 411,
through the gap and flows out the outlet tube 425 connected to the first chamber 401. During this
mixture is fed h the inlet tube 420, the mixture
process as the dialysate and carbon dioxide
small
moves upwards causing carbon dioxide to be ted from the dialysate thereby forming
carbon dioxide bubbles that are vented out through the microporous hydrophobic membrane 415.
The ate-free carbon e moves through and out the outlet tube 425. The ing
chamber can be placed at various locations in the dialysis flow, but preferably in the flow stream
immediately after the dialysate is subjected to filtration in sorbcnt canisters, depicted as 520 in
Figures 5a and 5b. It should be appreciated that, regardless of where the degassing chamber is
placed in the system, it should be vertically ined, with ne 415 at the top of the
device, in order to properly direct air bubbles h and out of the device 400.
Figure 1 shows a closed multi-pass hemodialyzer configured as a wearable dialysis
device 100 that, in one embodiment comprises a shuttle pump or dual-channel pulsatile pump
105 to propel both blood and dialysate h the device 100, a high flux, polysulfonc er
110 with 0.6 square meter membrane surface, a dialysate regeneration system 1 15 consisting of
three specially designed canisters containing a plurality of sorbcnts, such as 122, zirconium,
phosphate, 123, activated charcoal, and 121 urease, as well as reservoirs of electrolyte additives
1 16 and a pH-control t (not ; micro-pumps (not shown) for delivering heparin
and a reservoir
to the blood circuit, additives including Mg, Ca, K and sodium bicarbonate 118,
for excess ultrafiltrate 1 19, all at pre-specified flow rates; and a blood-leak/bubble detector and
120.
pump power~up and alarm/shutoff system
The main pump 105 uses a 3-Watt DC micro motor. The gear-head accommodates an
oscillating mechanism, which in conjunction with a dual-channel flow cartridge, allows
simultaneous pulsatile flows of both blood and the dialysate at controllable rates of 40-100
ml/min per channel. The cartridge allows both blood and dialysate to flow either in the same
direction or in opposite directions, depending on the configuration/location of the other system
components. It is preferred, however, that, when one channel propels fluid out of its
compressible chamber, the other l fills its ssible chamber, allowing for peak
pressure in one channel at the same time the pressure in the other channel is at its lowest level.
In one embodiment, the t ers of the t invention are filled (in order of
dialysate flow) with approximately the following amounts of sorbents:
121, Canister #1: 50 grams of urease, followed by thin filter paper, and then 335 grams of
ium phosphate;
122, Canister #2: 335 grams of zirconium phosphate, followed by thin filter paper, and
then 50 grams of s zirconium oxide; and
123, Canister #3: 150 grams of activated .
chassing device 124 is located in the fluidic circuit between urease canister 12], and
ium Phosphate er 122. Carbon dioxide gas generated by the urease — urea reaction
in canister l2l is removed by the degassing device 124, before the dialysate fluid is passed into
canister 122. Other positioning of the degassing device, within the circuit, is possible, in
particular after all the sorbent canisters, ing the charcoal canister, 123 as shown in figure
5a. It should be appreciated that the degassing device 124 could be located afier canister 122 and
before canister 123 or after canister 123 and before dialyzcr 110.
Another embodiment of the degassing device 124 is shown in Figures 5a and 5b. The
device 520 consists of a coil of gas pcrmcablc tubing, such as that manufactured by GORE, Inc.,
tubing part number MMT-RD-OOZA. In Figure 5a, the degassing device 520 is connected, via
tubing 522, to a dialyzcr. Figure Sb depicts the degassing device 520 connected to tubing 522.
This tube is 9 feet long, has an outside diameter of approximately 0.275” and a wall thickness of
approximately .025”. The coil assembly is approximately 2.25” outside diameter and
approximately 2.5” in height In this embodiment, the entire outer wall of the outside chamber is
gas permeable. Because gas can now diffuse through any portion of the outer wall, not just the
in nearly any
top as in the embodiment disclosed in Figure 4, the device can be placed
orientation, making it well suited for use with a wearable dialysis system such as that depicted in
Figure 1. In one embodiment of the device the total tube length is 9 feet. This size is designed to
yield an adequate surface area to provide gas l capability for a typical wearable artificial
kidney operating around the 24 hours a day, seven days a week with a dialysate and blood flow
rate at or below 100 ml/min. Shorter lengths of tubing (therefore possessing lower surface area)
can be used for removing less gas, such as if flow rates were lowered or longer lengths can be
used for increased gas removal capacity.
In operation, gas collects in a self generated pocket on the top of the many coils of the
gas ble tubing in device 520. This location of the gas pocket s depending on
orientation of the device. y dictating that the gas collects on whatever surface is “up” in
varying orientations. Since the entire length of the device is composed of gas permeable tubing,
no matter where the gas pocket collects it is able to escape.
ate packaging of the lube may include long serpentine shaped runs accommodating
the shape of a belt wom around the waist of a patient using a wearable artificial kidney. Thus the
embodiment pictured in Figure 5b is not exclusive to the functionality of the degassing device.
The key factor is that whatever shape the device takes the fluid path be composed of a gas
permeable tube of sufficient length, and therefore surface area, to remove the amount of gas
desired.
In another embodiment, shown in Figure 3, the degassing device 300 is a section of a
tube, a housing, a coil oftubing, or any other shape 310 that defines a chamber 325 and a
flowpath 305 therein. The external wall ofthe housing 310 comprises any material 315 that will
be sized so that the amount of gas passed equals or
pass gas but not fluid. The material 315 must
exceeds the amount of gas generated. Gas tion is a t of urea level in the patient and
dialysatc flow rate. Gas passed by the ing device 300 is a product of the wall area and the
of the fluid in the tube relative to the
gas permeability of the tube plus the internal pressure
external pressure on the tube. One ofordinary skill in the art would be able to select the
appropriate material for a given application based upon the given parameters.
In one embodiment, the degassing device comprises a GORE membrane that is between
0.5 feet to 16 feet long (more ularly 9 feet long), has an outer diameter of about 0.1 to 0.45
inches (more particularly .275 inches) and an inner diameter of about 0.1 to 0.4 inches (more
particularly .25 inches) and configured in any shape, including a tight coil. In one embodiment,
the aforementioned degassing device 300 removes substantially all gas from the dialysate at flow
tube
rates from about 20 mein to 200 ml/min (more particularly 100 ml/min) and/or at internal
below 5 psi). In one embodiment, the
res at or below 10 psi (more particularly at or
degassing device 300 is oned between a t canister (more particularly the charcoal
sorbent) and the dialyzer. In one embodiment, the degassing device 300 is positioned after the
urease canister and before the dialyzer.
PERFORMANCE EXAMPLE 1
Various configurations of the dialysis device 100 of Figure 1 were tested to evaluate their
operational performance and, in particular, the gas removal capability of the degassing device
124 and 520. Referring to Figure 2, after priming the is device with saline, the is
device 200 was connected to a large (40- to 80-litcr) reservoir 205 of properly formulated
aqueous solution (referred to as “blood” here, made out of fresh zed water or spent human
dialysate) accurately mimicking end stage renal disease (ESRD) typical human blood. This
“blood” was designed to approximate actual human composition and contained about 50 mg/dL
of BUN (Blood Urea-Nitrogen), 10 mg/dL of creatinine, 5 mmol/L of K, among other solutes.
No additives were provided and no ultrafiltration was performed; however. dialysate pH was
maintained at an optimal value by a manual injection ofsodium bicarbonate in order to measure
its effect on the volume of C02 produced. “Blood” and dialysatc samples were drawn every 30
s, and the samples were d for pH, BUN, and creatinine.
In one experiment, which used a Gore tube MMT-RD-OOZA, to fabricate degassing
device 520, sorbent canisters were packed with 50 grams of urease, 670 grams of zirconium
phosphate, 50 grams of hydrous zirconium oxide, and 150 grams of ted carbon, and
operated at an e blood and dialysate flow rates of 55.6 and 43.2 mL/min, pressure reading
oscillating ranges were measured to be: a) between pump and er #1: 300-400 mmHg, b)
between canisters #1 and #2: 150-220 mmHg, 0) between canisters #2 and #3: 55-65 mmHg; and
d) between dialyzer and pump: 2-35 1111an (rarely going below 0). The urea, measured as BUN
(Blood Urea-Nitrogen) when reacted with the Urease generated C02 in amounts dictated by the
flowrate and urea concentrations present. Such conditions were set up to mimic actual human
dialysis. Under these test conditions the degassing device successfully removed all the C02
generated.
While there has been illustrated and described what is at present considered to be a
preferred embodiment of the present ion, it will be understood by those skilled in the art
that various changes and modifications may be made, and equivalents may be substituted for
elements thereof without departing from the true scope of the invention. In on, many
modifications may be made to adapt a particular situation or al to the teachings of the
invention without departing from the central scope thereof. ore, it is intended that this
invention not be d to the particular embodiment disclosed as the best mode contemplated
for carrying out the invention, but that the invention will include all embodiments falling within
the scope ofthe appended claims.
WE
Claims (9)
- l. A dialysate circuit including: a. a dialysate regeneration system including ; b. a housing including an external wall, wherein the external wall is exposed to atmosphere and n the external wall includes a al that passes gas but does not pass liquid; and c. a dialyzer, wherein said housing is positioned between the urease and dialyzer.
- 2. The dialysate t of claim 1 or claim 2 wherein the housing includes at least one of a tube, a section of tubing, or a coil of .
- 3. The ate circuit of claim 2 wherein the housing includes a membrane that is between 0.5 feet to 16 feet long.
- 4. The dialysate circuit of claim 2 wherein the housing includes a membrane that has an outer diameter of about 0.1 to 0.45 inches.
- 5. The dialysate circuit of claim 2 wherein the housing includes a membrane that has an inner diameter of about 0.1 to 0.4 inches.
- 6. The dialysate t of any one of the preceding claims wherein the housing removes substantially all gas from the dialysate at flow rates from about 20 ml/min to 200 ml/min.
- 7. The dialysate circuit of any one of the preceding claims wherein the housing removes substantially all gas fiom the dialysate at internal pressures at or below 10 psi.
- 8. The dialysate circuit of any one of the preceding claims wherein the dialysate regeneration system includes charcoal and wherein said housing is positioned between the charcoal and dialyzer.
- 9. The ate circuit as claimed in claim 1 and as substantially herein described with reference to any one of
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ601028A NZ601028B (en) | 2008-01-18 | 2012-07-03 | Carbon Dioxide Gas Removal From a Fluid Circuit of a Dialysis Device |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2196508P | 2008-01-18 | 2008-01-18 | |
US61/021,965 | 2008-01-18 | ||
NZ586924A NZ586924A (en) | 2008-01-18 | 2009-01-16 | Carbon dioxide gas removal from a fluid circuit of a dialysis device with device having annular concentric housings |
NZ601028A NZ601028B (en) | 2008-01-18 | 2012-07-03 | Carbon Dioxide Gas Removal From a Fluid Circuit of a Dialysis Device |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ601028A NZ601028A (en) | 2013-03-28 |
NZ601028B true NZ601028B (en) | 2013-07-02 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8034161B2 (en) | Carbon dioxide gas removal from a fluid circuit of a dialysis device | |
JP6486416B2 (en) | Sensing system for detecting substances in dialysate | |
US9138524B2 (en) | Sensing system for detecting a substance in a dialysate | |
TWI619520B (en) | Sensing system for detecting a substance in a dialysate | |
NZ601028B (en) | Carbon Dioxide Gas Removal From a Fluid Circuit of a Dialysis Device | |
US11904079B2 (en) | Degassing unit | |
Ota et al. | A new method of urea removal using urease and expanded polytetrafluoroethylene membrane | |
CN118976167A (en) | Peritoneal dialysis equipment | |
NZ623899B2 (en) | Sensing system for detecting a substance in a dialysate |